Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century
Authors
Keywords
-
Journal
JOURNAL OF DRUG TARGETING
Volume 25, Issue 9-10, Pages 759-780
Publisher
Informa UK Limited
Online
2017-08-08
DOI
10.1080/1061186x.2017.1358729
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of NKTR-214 on the number and activity of CD8+ tumor infiltrating lymphocytes in patients with advanced renal cell carcinoma.
- (2017) Michael E. Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors
- (2017) Howard A. Burris et al. JOURNAL OF CLINICAL ONCOLOGY
- Two decades of glatiramer acetate: From initial discovery to the current development of generics
- (2017) Bianca Weinstock-Guttman et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type
- (2017) Beatriz Torre et al. MOLECULES
- Overcoming cellular barriers for RNA therapeutics
- (2017) Steven F Dowdy NATURE BIOTECHNOLOGY
- The evolving landscape of drug products containing nanomaterials in the United States
- (2017) Sheetal R. D'Mello et al. Nature Nanotechnology
- 2016 FDA drug approvals
- (2017) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- The effectiveness and safety of same-day versus next-day administration of long-acting granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced neutropenia: a systematic review
- (2017) Gary H. Lyman et al. SUPPORTIVE CARE IN CANCER
- Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
- (2017) Yuanyu Huang Molecular Therapy-Nucleic Acids
- Pharmacokinetic Considerations in Designing Pediatric Studies of Proteins, Antibodies, and Plasma-Derived Products
- (2016) Iftekhar Mahmood AMERICAN JOURNAL OF THERAPEUTICS
- Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population
- (2016) Qi Yang et al. ANALYTICAL CHEMISTRY
- Optimization of an Anti-poly(ethylene glycol) (anti-PEG) Cell-Based Capture System To Quantify PEG and PEGylated Molecules
- (2016) Wen-Wei Lin et al. ANALYTICAL CHEMISTRY
- Antibody-drug conjugates—an emerging class of cancer treatment
- (2016) Nikolaos Diamantis et al. BRITISH JOURNAL OF CANCER
- Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer
- (2016) S. R. Hingorani et al. CLINICAL CANCER RESEARCH
- NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models
- (2016) D. H. Charych et al. CLINICAL CANCER RESEARCH
- Long-term treatment with pegvisomant for acromegaly: a 10-year experience
- (2016) Ana M. Ramos-Leví et al. CLINICAL ENDOCRINOLOGY
- Well-defined hydroxyethyl starch-10-hydroxy camptothecin super macromolecule conjugate: cytotoxicity, pharmacodynamics research, tissue distribution test and intravenous injection safety assessment
- (2016) Guofei Li et al. DRUG DELIVERY
- Pre-existing anti–polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
- (2016) Nancy J. Ganson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
- (2016) Peter L. Turecek et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia
- (2016) N Khan et al. LEUKEMIA
- Phase II and phase III failures: 2013–2015
- (2016) Richard K. Harrison NATURE REVIEWS DRUG DISCOVERY
- Screening out irrelevant cell-based models of disease
- (2016) Peter Horvath et al. NATURE REVIEWS DRUG DISCOVERY
- The delivery of therapeutic oligonucleotides
- (2016) Rudolph L. Juliano NUCLEIC ACIDS RESEARCH
- A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer
- (2016) Melodi Javid Whitley et al. Science Translational Medicine
- High throughput toxicity screening and intracellular detection of nanomaterials
- (2016) Andrew R. Collins et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- On the road to personalised and precision geomedicine: medical geology and a renewed call for interdisciplinarity
- (2016) Maged N. Kamel Boulos et al. International Journal of Health Geographics
- How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes
- (2016) Araceli Muñoz-Garach et al. Diabetes Therapy
- From selection hits to clinical leads: progress in aptamer discovery
- (2016) Keith E Maier et al. Molecular Therapy-Methods & Clinical Development
- How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes
- (2016) Araceli Muñoz-Garach et al. Diabetes Therapy
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis
- (2016) Jack W. Scannell et al. PLoS One
- Efficacy of polyethylene glycol–conjugated bovine granulocyte colony-stimulating factor for reducing the incidence of naturally occurring clinical mastitis in periparturient dairy cows and heifers
- (2015) Renee L. Hassfurther et al. AMERICAN JOURNAL OF VETERINARY RESEARCH
- Lysosomal Physiology
- (2015) Haoxing Xu et al. Annual Review of Physiology
- Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating Factor
- (2015) Tara Arvedson et al. BIODRUGS
- Efficacy of a long-acting C-peptide analogue against peripheral neuropathy in streptozotocin-diabetic mice
- (2015) C. G. Jolivalt et al. DIABETES OBESITY & METABOLISM
- Establishment of the first international standard for PEGylated granulocyte colony stimulating factor (PEG-G-CSF): Report of an international collaborative study
- (2015) Meenu Wadhwa et al. JOURNAL OF IMMUNOLOGICAL METHODS
- PEGylated Biopharmaceuticals
- (2015) Inge A. Ivens et al. TOXICOLOGIC PATHOLOGY
- Product quality for nanomaterials: current U.S. experience and perspective
- (2015) Katherine M. Tyner et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis
- (2015) Jeffrey Cohen et al. JAMA Neurology
- The Impact of Preclinical Irreproducibility on Drug Development
- (2015) LP Freedman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Understanding Pharmaceutical Quality by Design
- (2014) Lawrence X. Yu et al. AAPS Journal
- Quantitative Analysis of Polyethylene Glycol (PEG) and PEGylated Proteins in Animal Tissues by LC-MS/MS Coupled with In-Source CID
- (2014) Jiachang Gong et al. ANALYTICAL CHEMISTRY
- Trastuzumab emtansine: mechanisms of action and drug resistance
- (2014) Mark Barok et al. BREAST CANCER RESEARCH
- Glycoconjugate vaccines: an update
- (2014) Mairi Vella et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Polymer therapeutics: Top 10 selling pharmaceuticals — What next?
- (2014) Ruth Duncan JOURNAL OF CONTROLLED RELEASE
- Comparative clinical pharmacokinetics of antibody-drug conjugates in first-in-human Phase 1 studies
- (2014) Antoine Deslandes mAbs
- Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
- (2014) J. E. Zuckerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
- (2014) E. Phillips et al. Science Translational Medicine
- Role of Endosomes and Lysosomes in Human Disease
- (2014) F. R. Maxfield Cold Spring Harbor Perspectives in Biology
- Concerns over use of hydroxyethyl starch solutions
- (2014) C. S. Hartog et al. BMJ-British Medical Journal
- How to Regulate Nonbiological Complex Drugs (NBCD) and Their Follow-on Versions: Points to Consider
- (2013) Huub Schellekens et al. AAPS Journal
- An estimation of the number of cells in the human body
- (2013) Eva Bianconi et al. ANNALS OF HUMAN BIOLOGY
- What is the total number of protein molecules per cell volume? A call to rethink some published values
- (2013) Ron Milo BIOESSAYS
- Discussion about Several Potential Drawbacks of PEGylated Therapeutic Proteins
- (2013) Fan Zhang et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate
- (2013) Ruth Duncan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Next-generation nanomedicines and nanosimilars: EU regulators’ initiatives relating to the development and evaluation of nanomedicines
- (2013) Falk Ehmann et al. Nanomedicine
- Meta-analysis of inter-patient pharmacokinetic variability of liposomal and non-liposomal anticancer agents
- (2013) Ryan F. Schell et al. Nanomedicine-Nanotechnology Biology and Medicine
- The Immunogenicity of Polyethylene Glycol: Facts and Fiction
- (2013) Huub Schellekens et al. PHARMACEUTICAL RESEARCH
- Bioanalysis of antibody–drug conjugates: American Association of Pharmaceutical Scientists Antibody–Drug Conjugate Working Group position paper
- (2013) Boris Gorovits et al. Bioanalysis
- Multiscale mechanobiology: mechanics at the molecular, cellular, and tissue levels
- (2013) Chin-Lin Guo et al. Cell and Bioscience
- Polymer therapeutics-prospects for 21st century: The end of the beginning
- (2012) Ruth Duncan et al. ADVANCED DRUG DELIVERY REVIEWS
- Cancer nanomedicines: So many papers and so few drugs!
- (2012) Vincent J. Venditto et al. ADVANCED DRUG DELIVERY REVIEWS
- Analytical Measurement of PEGylated Molecules
- (2012) Tian-Lu Cheng et al. BIOCONJUGATE CHEMISTRY
- Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging
- (2012) Jeffrey K. Mito et al. CANCER
- Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance
- (2012) W. C. Zamboni et al. CLINICAL CANCER RESEARCH
- Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
- (2012) Uma Mahadevan et al. Clinical Gastroenterology and Hepatology
- Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
- (2012) Ricardo P Garay et al. Expert Opinion on Drug Delivery
- Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory
- (2012) Rachael M. Crist et al. Integrative Biology
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- Endocytosis and Intracellular Trafficking as Gateways for Nanomedicine Delivery: Opportunities and Challenges
- (2012) Ruth Duncan et al. MOLECULAR PHARMACEUTICS
- Raise standards for preclinical cancer research
- (2012) C. Glenn Begley et al. NATURE
- Polymer therapeutics as nanomedicines: new perspectives
- (2011) Ruth Duncan CURRENT OPINION IN BIOTECHNOLOGY
- Analytical methods for physicochemical characterization of antibody drug conjugates
- (2011) Aditya Wakankar et al. mAbs
- Nanomedicine(s) under the Microscope
- (2011) Ruth Duncan et al. MOLECULAR PHARMACEUTICS
- Mucin dynamics and enteric pathogens
- (2011) Michael A. McGuckin et al. NATURE REVIEWS MICROBIOLOGY
- Transfer of PAMAM dendrimers across human placenta: Prospects of its use as drug carrier during pregnancy
- (2010) Anupa R. Menjoge et al. JOURNAL OF CONTROLLED RELEASE
- The joy of discovery
- (2010) Christian de Duve NATURE
- Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds
- (2010) Pilar Rivera Gil et al. PHARMACOLOGICAL RESEARCH
- Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt
- (2009) Ruth Duncan ADVANCED DRUG DELIVERY REVIEWS
- Polymeric carriers: Preclinical safety and the regulatory implications for design and development of polymer therapeutics
- (2009) Rogério Gaspar et al. ADVANCED DRUG DELIVERY REVIEWS
- Dextrin−Phospholipase A2: Synthesis and Evaluation as a Bioresponsive Anticancer Conjugate
- (2009) Elaine L. Ferguson et al. BIOMACROMOLECULES
- Intracellular fate of bioresponsive poly(amidoamine)s in vitro and in vivo
- (2009) Simon C.W. Richardson et al. JOURNAL OF CONTROLLED RELEASE
- Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer
- (2009) Corey J. Langer et al. Journal of Thoracic Oncology
- Quality by design for biopharmaceuticals
- (2009) Anurag S Rathore et al. NATURE BIOTECHNOLOGY
- Lessons from 60 years of pharmaceutical innovation
- (2009) Bernard Munos NATURE REVIEWS DRUG DISCOVERY
- Polymer Masked−Unmasked Protein Therapy. 1. Bioresponsive Dextrin−Trypsin and −Melanocyte Stimulating Hormone Conjugates Designed for α-Amylase Activation
- (2008) Ruth Duncan et al. BIOMACROMOLECULES
- Dextrin–rhEGF conjugates as bioresponsive nanomedicines for wound repair
- (2008) J HARDWICKE et al. JOURNAL OF CONTROLLED RELEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now